Induction with infliximab and a plant-based diet as first-line (IPF) therapy for moderate-to-severe to severe ulcerative colitis

被引：0
|
作者：
Chiba, Mitsuro [1 ]
Nakane, Kunio [1 ]
Tsuji, Tsuyotoshi [1 ]
Tsuda, Satoko [1 ]
Ishii, Hajime [1 ]
Ohno, Hideo [1 ]
Watanabe, Kenta [1 ]
Ito, Mai [1 ]
Obara, Yu [1 ]
Komatsu, Masafumi [1 ]
Sugawara, Takeshi [2 ]
机构：
[1] Akita City Hosp, Dept Internal Med GI Hepatol, Akita, Japan
[2] Nakadori Gen Hosp, Dept Internal Med GI Hepatol, Akita, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
ulcerative colitis; infliximab; plant-based diet; remission; inflammatory bowel disease;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OE-0103 (P
引用
收藏
页码：483 / 483
页数：1
相关论文
共 50 条
  • [41] Infliximab as first-line therapy in severe pediatric Crohn disease
    de Ridder, Lissy
    Benninga, Marc A.
    Taminiau, Jan A. J. M.
    Hommes, Daniel W.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2006, 43 (03): : 388 - 390
  • [42] CONTINUING 5-ASA THERAPY IN MODERATE-TO-SEVERE ULCERATIVE COLITIS PATIENTS ESCALATED TO INFLIXIMAB IS NO MORE EFFECTIVE THAN USING INFLIXIMAB ALONE
    Joshi, Harshad
    Wong, Karen
    Kroeker, Karen I.
    Dieleman, Levinus A.
    Halloran, Brendan P.
    Baumgart, Daniel C.
    Peerani, Farhad
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S663 - S663
  • [43] Biologics for the treatment of moderate-to-severe ulcerative colitis in pediatric patients
    Albenberg, Lindsey G.
    Mamula, Petar
    Kelsen, Judith R.
    [J]. PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 51 - 58
  • [44] Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update
    Burri, Emanuel
    Maillard, Michel H.
    Schoepfer, Alain M.
    Seibold, Frank
    Van Assche, Gert
    Riviere, Pauline
    Laharie, David
    Manz, Michael
    [J]. DIGESTION, 2020, 101 (SUPPL 1) : 2 - 15
  • [45] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis REPLY
    Sands, Bruce E.
    Schreiber, Stefan
    Lirio, Richard A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 93 - 94
  • [46] Cost-Effectiveness of Infliximab Scheduled Maintenance Treatment for the Management of Patients With Moderate-to-Severe Ulcerative Colitis
    Monfared, Amir A. Tahami
    Feagan, Brian G.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S637 - S637
  • [47] A Retrospective Multicenter Survey on Infliximab Efficacy and Safety in Moderate-to-Severe and Steroid-Dependent Ulcerative Colitis
    Cappello, Maria
    Mazza, Marta
    Costantino, Giuseppe
    Fries, Walter
    Privitera, Antonino C.
    Mastronardi, Mauro
    Buccianti, Nello
    Castiglione, Fabiana
    Rispo, Antonio
    Lauria, Angelo
    Marasco, Raffaella
    Almasio, Piero L.
    Bossa, Fabrizio
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S436 - S436
  • [48] Intensified Infliximab Induction Dosing in Acute Severe Ulcerative Colitis
    Syed, Nauroz
    Christian, Kaci E.
    Kelly, Sean
    Wentz, Alicia
    Cross, Ray, Jr.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S377 - S377
  • [49] Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
    Brandse, Johannan F.
    Mathot, Ron A.
    van der Kleij, Desiree
    Rispens, Theo
    Ashruf, Yael
    Jansen, Jeroen M.
    Rietdijk, Svend
    Lowenberg, Mark
    Ponsioen, Cyriel Y.
    Singh, Sharat
    van den Brink, Gijs R.
    D'Haens, Geert R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (02) : 251 - +
  • [50] Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children
    Hyams, Jeffrey
    Crandall, Wallace
    Kugathasan, Subra
    Griffiths, Anne
    Olson, Allan
    Johanns, Jewel
    Liu, Grace
    Travers, Suzanne
    Heuschkel, Robert
    Markowitz, James
    Cohen, Stanley
    Winter, Harland
    Veereman-Wauters, Gigi
    Ferry, George
    Baldassano, Robert
    [J]. GASTROENTEROLOGY, 2007, 132 (03) : 863 - 873
12345